On December 4, 2025, Radical Health emerged from stealth and announced a $5 million Pre-Seed funding round led by Khosla Ventures. Wilson Sonsini Goodrich & Rosati advised Radical Health on the transaction.

Radical Health's goal is to build an AI Oncologist that gives every patient access to world-class cancer expertise. The company’s platform uses data from over 11 million patients across top cancer centers and all medical research ever published.

The Wilson Sonsini team that advised Radical Health includes Yokum Taku, Stacy Kim, and Michael Soud.

For more information, please see Radical Health's LinkedIn post. Additional coverage can be found on Fortune.